Homing and engraftment of bone marrow cells derived from different donors in a murine model of sensitization

References

• Schrier SL, Angelucci E. New strategies in the treatment of the thalassemias. Annu Rev Med. 2005;56:157–71.
   PubMed Web of Science ®Google Scholar
• Kremastinos DT, Farmakis D, Aessopos A, Hahalis G, Hamodraka E, Tsiapras D, et al. Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail. 2010;3:451–8.
   PubMed Web of Science ®Google Scholar
• Noetzli LJ, Coates TD, Wood JC. Pancreatic iron loading in chronically transfused sickle cell disease is lower than in thalassaemia major. Br J Haematol. 2011;152:229–33.
   PubMed Web of Science ®Google Scholar
• Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43–70.
   PubMed Web of Science ®Google Scholar
• Marsh J, Socie G, Tichelli A, Schrezenmeier H, Hochsmann B, Risitano AM, et al. Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Br J Haematol. 2010;150:377–9.
   PubMed Web of Science ®Google Scholar
• Friedman DF, Lukas MB, Jawad A, Larson PJ, Ohene-Frempong K, Manno CS. Alloimmunization to platelets in heavily transfused patients with sickle cell disease. Blood. 1996;88:3216–22.
   PubMed Web of Science ®Google Scholar
• Lo SC, Chang JS, Lin SW, Lin DT. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients. Transfusion. 2005;45:761–5.
   PubMed Web of Science ®Google Scholar
• Eikmans M, Waanders MM, Roelen DL, van Miert PP, Anholts JD, de Fijter HW, et al. Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients. Transplantation. 2010;90:1192–9.
   PubMed Web of Science ®Google Scholar
• Fang JP, Xu LH, Yang XG, Wu YF, Weng WJ, Xu HG. Panel reactive antibody in thalassemic serum inhibits proliferation and differentiation of cord blood CD34+ cells in vitro. Pediatr Hematol Oncol. 2009;26:338–44.
   PubMed Web of Science ®Google Scholar
• Ciurea SO, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ, et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation. 2009;88:1019–24.
   PubMed Web of Science ®Google Scholar
• Kataoka K, Yamamoto G, Nannya Y, Yoshimi A, Okada S, Asai T, et al. Successful engraftment following HLA-mismatched cord blood transplantation for patients with anti-HLA Abs. Bone Marrow Transplant. 2008;42:129–30.
   PubMed Web of Science ®Google Scholar
• Khoury R, Abboud MR. Stem-cell transplantation in children and adults with sickle cell disease: an update. Expert Rev Hematol. 2011;4:343–51.
   PubMed Web of Science ®Google Scholar
• Gaziev D, Galimberti M, Lucarelli G, Polchi P, Giardini C, Angelucci E, et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants. Bone Marrow Transplant. 2000;25:815–21.
   PubMed Web of Science ®Google Scholar
• Li CG, Li CF, Li Q, Li M. Thalassemia incidence and treatment in China with special reference to Shenzhen City and Guangdong province. Hemoglobin. 2009;33:296–303.
   PubMed Web of Science ®Google Scholar
• Petrányi GG, Réti M, Harsányi V, Szabó J. Immunologic consequences of blood transfusion and their clinical manifestations. Int Arch Allergy Immunol. 1997;114:303–15.
   PubMed Web of Science ®Google Scholar
• Andreu G, Perrot JY, Pirenne F, Boccaccio C. The effect of ultraviolet B light on antigen-presenting cells: implications for transfusion-induced sensitization. Semin Hematol. 1992;29:122–31.
   PubMed Web of Science ®Google Scholar
• Dooner M, Cerny J, Colvin G, Demers D, Pimentel J, Greer D, et al. Homing and conversion of murine hematopoietic stem cells to lung. Blood Cells Mol Dis. 2004;32:47–51.
   PubMed Web of Science ®Google Scholar
• Roda E, Coccini T, Acerbi D, Castoldi AF, Manzo L. Comparative in vitro and ex-vivo myelotoxicity of aflatoxins B1 and M1 on haematopoietic progenitors (BFU-E, CFU-E, and CFU-GM): species-related susceptibility. Toxicol In Vitro. 2010;24:217–23.
   PubMed Web of Science ®Google Scholar
• Lock RB, Liem N, Farnsworth ML, Milross CG, Xue C, Tajbakhsh M, et al. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse. Blood. 2002;99:4100–8.
   PubMed Web of Science ®Google Scholar
• Fang J, Huang S, Chen C, Zhou D, Li CK, Li Y, et al. Umbilical cord blood transplantation in Chinese children with beta-thalassemia. J Pediatr Hematol Oncol. 2004;26:185–9.
   PubMed Web of Science ®Google Scholar
• Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev. 2008;22:53–63.
   PubMed Web of Science ®Google Scholar
• Fang JP, Xu LH. Hematopoietic stem cell transplantation for children with thalassemia major in China. Pediatr Blood Cancer. 2010;55:1062–5.
   PubMed Web of Science ®Google Scholar
• Smiers FJ, Krishnamurti L, Lucarelli G. Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends. Pediatr Clin North Am. 2010;57:181–205.
   PubMed Web of Science ®Google Scholar
• Nagata S, Okano S, Yonemitsu Y, Nakagawa K, Tomita Y, Yoshikai Y, et al. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice. Transplantation. 2006;82:689–98.
   PubMed Web of Science ®Google Scholar
• Xu H, Chilton PM, Tanner MK, Huang Y, Schanie CL, Dy-Liacco M, et al. Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. Blood. 2006;108:3611–9.
   PubMed Web of Science ®Google Scholar
• Taylor PA, Ehrhardt MJ, Roforth MM, Swedin JM, Panoskaltsis-Mortari A, Serody JS, et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood. 2007;109:1307–15.
   PubMed Web of Science ®Google Scholar